2012 Global Antithrombin III Market Outlook: Test Volume Forecasts by Country and Market Segment
The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and AT III testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the AT III testing closer to the patient, creating additional opportunities and challenges for suppliers.This report presents a detailed analysis of the AT III testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forecasts by country and market segment.
The report examines market applications of chromogenic substrates, monoclonal antibodies, immunoassays, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
Contains 197 pages and 8 tables
The report examines market applications of chromogenic substrates, monoclonal antibodies, immunoassays, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
Contains 197 pages and 8 tables
I. INTRODUCTION
II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Introduction
B. Antithrombin III: Clinical Significance: Clinical Significance and Current Laboratory Procedures
C. Instrumentation Review
1. Chromogenic Substrates
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
a. Applications
b. Technological Principle
c. Enzyme Immunoassays (EIA)
f. Immunoprecipitation
4. Microcomputers
5. Automation
6. Robotics
7. DNA Probes
a. Overview
b. Amplification Methods
9. Dry Chemistry
10. Biosensors
III. FRANCE: TEST VOLUME FORECASTS BY MARKET SEGMENT
IV. GERMANY: TEST VOLUME FORECASTS BY MARKET SEGMENT
V. ITALY: TEST VOLUME FORECASTS BY MARKET SEGMENT
VI. JAPAN: TEST VOLUME FORECASTS BY MARKET SEGMENT
VII. SPAIN: TEST VOLUME FORECASTS BY MARKET SEGMENT
VIII. UK: TEST VOLUME FORECASTS BY MARKET SEGMENT
IX. USA: TEST VOLUME FORECASTS BY MARKET SEGMENT
X. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
XI. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types Of Distributors
7. Market Segmentation
XII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XIII. COMPETITIVE ASSESSMENTS
Test Volume Forecasts by Country and Market Segment
II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Introduction
B. Antithrombin III: Clinical Significance: Clinical Significance and Current Laboratory Procedures
C. Instrumentation Review
- Introduction
- Benk Hemolab
- Benk TRT Thrombotimer
- Bio/Data MCA 310
- Bio/Data MCA 210
- Bio/Data PAP-4C D/4D/4C
- Cardiovascular Diagnostics COAG
- Diagnostica Stago STA Compact
- Diagnostica Stago STA-R
- Diagnostica Stago Star 4/8
- Helena Laboratories Cascade 480
- Helena Laboratories Cascade M
- Helena Laboratories PACKS-4
- Helena THOR
- Instrumentation Laboratory ACL 100 and 1000 series
- Instrumentation Laboratory ACL6000
- Instrumentation Laboratory ACL7000
- Instrumentation Laboratory ACL9000
- Instrumentation Laboratory Electra 1000C
- Instrumentation Laboratory Electra 1400C
- Instrumentation Laboratory Electra 1600/C
- Instrumentation Laboratory Electra 1800C
- Instrumentation Laboratory Futura
- ITC Hemochron 8000
- Roche Diagnostics CoaguChek
- Siemens BCS
- Siemens BCT
- Siemens BF II/Fibrintimer Series
- Sysmex CA-50
- Sysmex CA-500
- Sysmex CA-1500
- Sysmex CA-5000/CA-1000
- Sysmex CA-6000
- Sysmex CA-7000
- Teco Coatron II/Jr./AccuStasis 5000
- Trinity Biotech Amax CS190
- Trinity Biotech Amax CS400
- Trinity Biotech Coag-A-Mate Max
- Trinity Biotech KC 40, 4A, 1A Series
- Trinity Biotech MDA 180
- Trinity Biotech Coag-A-Mate MTX
- Trinity Biotech Coag-A-Mate RA4
- Trinity Biotech Coag-A-Mate XC/Plus
- Trinity Biotech Coag-A-Mate XM
1. Chromogenic Substrates
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
a. Applications
b. Technological Principle
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- EMIT
- Dot Immunobinding Assays
- Capillary Immunoassays
- Enzyme Amplification
- Electrochemical Immunoassay
- Fluorescence Polarization
- Time-Resolved Pulse Fluorescence
- Fluorescence Lifetime
f. Immunoprecipitation
4. Microcomputers
5. Automation
6. Robotics
7. DNA Probes
a. Overview
b. Amplification Methods
- PCR
- Ligase Chain Reaction
- Branched DNA
- Q-Beta Replicase
- NASBA
- SDA
- 3 SR
- HPA
- Two-Tiered System
- LAT
9. Dry Chemistry
10. Biosensors
III. FRANCE: TEST VOLUME FORECASTS BY MARKET SEGMENT
IV. GERMANY: TEST VOLUME FORECASTS BY MARKET SEGMENT
V. ITALY: TEST VOLUME FORECASTS BY MARKET SEGMENT
VI. JAPAN: TEST VOLUME FORECASTS BY MARKET SEGMENT
VII. SPAIN: TEST VOLUME FORECASTS BY MARKET SEGMENT
VIII. UK: TEST VOLUME FORECASTS BY MARKET SEGMENT
IX. USA: TEST VOLUME FORECASTS BY MARKET SEGMENT
X. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
XI. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types Of Distributors
7. Market Segmentation
XII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XIII. COMPETITIVE ASSESSMENTS
- Abbott
- American Diagnostica
- Avocet Medical
- Axis-Shield
- Beckman Coulter
- Becton Dickinson
- Bio/Data Corporation
- Biosite
- Chrono-Log
- Corgenix Medical
- Diagnostica Stago
- Helena Laboratories
- HYPEN BioMed
- Instrumentation Laboratory
- ITC
- Nanogen
- Roche
- Siemens
- Sienco
- Sysmex
- Thermo Fischer
- Trinity Biotech
- ZyCare
Test Volume Forecasts by Country and Market Segment
LIST OF TABLES
Major Companies Developing or Marketing Antithrombin III Tests
France Antithrombin III Test Volume Forecasts by Market Segment
Germany Antithrombin III Test Volume Forecasts by Market Segment
Italy Antithrombin III Test Volume Forecasts by Market Segment
Japan Antithrombin III Test Volume Forecasts by Market Segment
Spain Antithrombin III Test Volume Forecasts by Market Segment
U.K. Antithrombin III Test Volume Forecasts by Market Segment
U.S.A. Antithrombin III Test Volume Forecasts by Market Segment
Major Companies Developing or Marketing Antithrombin III Tests
France Antithrombin III Test Volume Forecasts by Market Segment
Germany Antithrombin III Test Volume Forecasts by Market Segment
Italy Antithrombin III Test Volume Forecasts by Market Segment
Japan Antithrombin III Test Volume Forecasts by Market Segment
Spain Antithrombin III Test Volume Forecasts by Market Segment
U.K. Antithrombin III Test Volume Forecasts by Market Segment
U.S.A. Antithrombin III Test Volume Forecasts by Market Segment